Central Venous Catheters and Upper Extremity DVT: Update, Diagnosis and Management
|
|
- Polly Curtis
- 8 years ago
- Views:
Transcription
1 Central Venous Catheters and Upper Extremity DVT: Update, Diagnosis and Management David Hahn, MD Interventional Radiology NorthShore University HealthSystem
2 Objectives Discuss the epidemiology and clinical impact of catheter related venous thrombosis Examine various strategies in the management of catheter related UEDVT Discuss the literature and national guidelines for upper extremity venous thrombosis Assess current practices for the management of PICCrelated DVT
3 prog ress - A forward or onward movement - Gradual betterment; especially: the progressive betterment of mankind Merriam-Webster Dictionary
4 Central Venous Catheters (CVCs) Historical Perspective: 1656 Sir Christopher Wren: first attempt at IV nutrition/ drugs in dogs: Goose quill attached to a pig s bladder, administered wine, ale and opium 1667 Major: infused saline into human antecubital vein via silver cannula and pig s bladder + +
5 Central Venous Catheters (CVCs) Historical Perspective: 1929 Berlin, Werner Forrsmann: originator of central venous catheter technique But he was not the only one
6 Central Venous Catheters (CVCs) Historical Perspective: 1912 Chemotherapeutic Era, Bleichroeder and Unger believed chemotherapeutic agent should be applied as close as possible to the diseased organ 1931 Forrsmann: conceived idea of drug delivery into right heart during emergency surgery; went on to win the Nobel Prize for Medicine 1956
7 Central Venous Catheters (CVCs) Historical Perspective: Long term CVCs first available in Broviac et al. improved design 1975 PICC line: Hoshal VL. "Total intravenous nutrition with peripherally inserted silicone elastomer central venous catheters". Arch Surg 110 (5): Dr. Robert O. Hickman; tunneled design and cuff Central Venous Catheters (Wiley Series in Nursing) Andy Bodenham (Author), Helen Hamilton (Editor). Wiley-Blackwell, 2009.
8 Deep Venous Thrombosis 130, ,000 cases in the U.S. per year DVT (lower extremity)= 0.1% incidence, increasing with age to 1% in elderly UEDVT= 1-4% all episodes of DVT Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and casefatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151:
9 Deep Venous Thrombosis Deep venous thrombosis (DVT) and thromboembolism include a complex spectrum of pathological conditions that are categorized by: 1. Etiology 2. Location a. primary b. secondary (ie from catheter, hypercoag.) a. upper extremity b. lower extremity Primary DVT of the lower extremity is a common clinical problem with significant risk for morbidity (postphlebitic syndrome) and mortality (pulmonary embolism).
10 Upper Extremity Deep Venous Thrombosis 1-4% of all causes of venous thrombosis 30% Primary DVT includes: thoracic outlet syndrome, effort thrombosis, and idiopathic venous thrombosis 70% Secondary DVT includes: central venous catheters, transvenous pacemakers, or cancer (thrombophilia)
11 Incidence of Catheter-Related Upper Extremity Venous Thrombosis Recent placement of a central venous catheter increases the risk for upper-extremity deep vein thrombosis (DVT) by 5- to 7-fold. Arch Intern Med 2000; 160: Upper extremity DVT is 2.6 to 8x more likely among patients with active cancer; a central venous catheter increases that risk. J Thromb Haemost 2005; 3:
12 UEDVT Symptoms Arm edema/swelling Shoulder/neck discomfort Pain Head fullness Facial edema Vertigo Dyspnea fevers
13 Signs and symptoms of upper extremity venous thrombosis include arm swelling, erythema, pain, distal paresthesias, and prominence of subcutaneous collateral veins along the ipsilateral chest wall. Arm remains swollen after removal of PICC
14 Incidence of Catheter-Related Deep Venous Thrombosis of the Upper Extremity Asymptomatic upper extremity venous thrombosis has been reported to occur in 20% 60% of patients with a central venous catheter. Symptomatic DVT has been reported to occur in 0% - 30% of patients with a central venous catheter.
15 Inadvertent PICC removal one day post placement Allen a et al. JVIR 2000; 11:
16 42 y/o female with ESRD, HTN, lupus presenting with malfunctioning HD catheter; pulling clots
17
18
19 UEDVT and PE Owens CA et al. JVIR 2010; 21: Review of literature: 28 publications, 3747 cases UEDVT Rate of PE: 5.6% Mortality from PE: 0.7%
20 PICC associated risk factors Young age Hx of DVT Discharge to skilled nursing facility Amphotericin B therapy Cancer treatment Large diameter catheters; high catheter to lumen ratio Evans RS et al. AMIA 2007 Symposium Proceedings
21 Chest 2010;138; Evans RS et al. Risk of Symptomatic DVT Associated With Peripherally Inserted Central Catheters 2014 PICCs inserted in 1728 patients RISK FACTORS FOR PICC-ASSOCIATED DVT: -prior DVT -surgery lasting >1 hour -larger catheter size (5F or greater)
22 Chest 2010;138; Evans RS et al. Risk of Symptomatic DVT Associated With Peripherally Inserted Central Catheters
23 Catheter size: The Triple Lumen PICC (The Holy Grail of the ICU) Trerotola SO et al. Radiology 2010: 256(1) Prospective, 1:1 randomization 6F TL PICC vs. central line PICC team/ir team placed at bedside US done at PICC removal to assess for clot N= 50 (167 patients planned); enrollment stopped, reached clinical equipoise 58% venous thrombosis rate (both symptomatic and asymptomatic) 20% symptomatic Don t use 6F triple lumen PICCs!!!
24 Five days ago a 30 year-old man developed a post-operative infection and a double lumen PICC was placed for administration of parenteral antibiotic therapy. As a member of your hospital s PICC nursing team you have been asked to evaluate his right upper arm. You examine the patient and discover that he has moderate edema of his entire right upper extremity and he complains of intermittent pain in his right shoulder region. He states that the edema of his right arm developed yesterday but significantly worsened overnight.
25 Upon further examination you notice mild tenderness and mild erythema at the PICC insertion site but no clear evidence of local infection. The PICC continues to work well for delivery of antibiotic therapy and blood draws. What is your diagnosis and treatment plan?
26 Catheter Related UEDVT Management Options: Removal of PICC Leave PICC in place Anticoagulation Thrombolysis Observation of extremity / re-ultrasound
27 Diagnosis: PICC associated upper extremity venous thrombosis Management: 1) Removal of PICC 2) Placement of new PICC in a new location 3) Oral anticoagulation therapy
28 PICC-related thrombosis
29 tract of old catheter thrombus adherent to SVC Venogram after removal of catheter
30 Risk Factors Associated with Central Venous Catheter Related Thrombosis Technical Larger catheter diameter Larger number of catheter lumens Catheter tip malposition Two or more insertion attempts Left-sided placement Subclavian vein insertion Patient and Vascular Catheter-associated infection Fibrinous catheter lumen occlusion Extrinsic vascular compression Treatment-Related L-asparaginase Estrogen or progesterone agents Recombinant human Interleukin-2 Granulocyte-macrophage CSF Thalidomide JNCCN 2006;4:
31 Insertion of a PICC causes significant trauma to the vein
32 Virchow s Triad Rudolph Virchow Theorized about the etiology of thrombus formation in veins published these ideas as they related to the pathophysiology of PE
33 damage to cephalic vein Damage (thrombus, fibrosis) to cephalic vein due to previous PICC
34 Stenosis and thrombosis of cephalic vein due to PICC
35 PICC-related stenosis may progress to chronic venous occlusion
36 collateral veins occlusion of brachiocephalic vein Venous hypertension due to occlusion of left brachiocephalic vein dilatation of veins
37 CLOT E V O L U T I O N Clot forms and gets worse R E S O L U T I O N Biological process of clearing clot
38 Retrospective review of 101 patients with catheter-related deep venous thrombosis of the upper extremity Two study groups: DVT resolved vs. DVT did not resolve All patients had ultrasound imaging
39 DVT DVT Total Resolved Not Resolved # Patients Catheter duration (days) Catheter removed Catheter not removed Anticoagulated
40 Duration of Catheter Placement Jones MA et al. J Vasc Surg 2010; 51: The average duration of catheter placement was 127 days. When central venous catheters were in place days, 26% of patients had resolution of thrombus When central venous catheters were in place >90 days, 42% of patients had resolution of thrombus Conclusion: Resolution of DVT was not affected by the length of time the catheter was in place.
41 Duplex Ultrasound Results Jones MA et al. J Vasc Surg 2010; 51: Removed Not Removed (n =77) (n =24) Resolved 52% 25% Partial resolution 23% 12% No change 18% 33% Progression 6% 29%
42 Influence of Combined Catheter Removal and Anticoagulation Jones MA et al. J Vasc Surg 2010; 51: Catheters were removed from 77% of 101 patients with upper extremity DVT Anticoagulation was used in 62% Both catheter removal and anticoagulation were used in 49%. In multivariate analysis, only catheter removal predicted likelihood of thrombus resolution (P=0.025).
43 Catheter Removal Jones MA et al. J Vasc Surg 2010; 51: Complete resolution DVT occurred in 52% of patients when the catheter was removed. Complete resolution DVT occurred in 25% of patients when the catheter was NOT removed.
44 Outcome of New Site Catheter Placement Jones MA et al. J Vasc Surg 2010; 51: patients had removal of initial catheter and placement of a new catheter at a new site presumably, not involved with thrombus. A new upper extremity DVT developed in association with the new catheter in 12 of these 14 (86%). Three (25%) of these 12 patients were receiving anticoagulation therapy when the old catheter was removed and the new catheter was placed in a different anatomic site.
45 Conclusions Removal of a central venous catheters associated with thrombus and subsequent placement of a new central venous access at a new site almost always resulted in new DVT. The implication is that it may be best to leave the catheter in place as long as it is needed, functions, and is not infected and then remove the catheter once it is no longer required for therapy. Such an algorithm will limit the development of DVT and may not adversely affect resolution of the initial DVT.
46 Clinical Practice Guidelines
47 8.1 For patients with acute upper-extremity DVT we recommend initial treatment with therapeutic doses of low molecular weight heparin, unfractionated heparin, or fondaparinux, as described for leg DVT
48 For patients with acute DVT, we recommend initial treatment with low molecular weight heparin, unfractionated heparin, or fondaparinux for at least 5 days and until the INR is > 2.0 for 24 h In patients with acute DVT, we recommend initiation of Coumadin together with LMWH, UFH, or fondaparinux on the first treatment day.
49 For patients with acute UEDVT, we recommend treatment with Coumadin for > 3 months For patients who have UEDVT in association with a central venous catheter that is removed, we do not recommend that the duration of long-term anticoagulant treatment be shortened to < 3 months
50 compression sleeve In patients with UEDVT who have persistent edema and pain, we suggest elastic bandages or elastic compression sleeves to reduce symptoms of post-thrombotic syndrome of the upper extremity
51 For most patients with UEDVT in association with a central venous catheter we suggest that the catheter not be removed if it is functional and there is an ongoing need for the catheter
52 Conclusions Management of catheter-related upper extremity deep venous thrombosis : Follow ACCP Guidelines (Chest 2008; 133:454S 545S) If the catheter is still needed and still works then do not remove. Treat with oral anticoagulation for 3 months
53 Discussion
Confirmed Deep Vein Thrombosis (DVT)
Confirmed Deep Vein Thrombosis (DVT) Information for patients What is deep vein thrombosis? Blood clotting provides us with essential protection against severe loss of blood from an injury to a vein or
More informationVenous Thromboembolic Treatment Guidelines
Venous Thromboembolic Treatment Guidelines About the NYU Venous Thromboembolic Center (VTEC) The center s mission is to deliver advanced screening, detection, care, and management services for patients
More informationPeripherally Inserted Central Catheter (PICC) for Outpatient
Peripherally Inserted Central Catheter (PICC) for Outpatient Introduction A Peripherally Inserted Central Catheter, or PICC line, is a thin, long, soft plastic tube inserted into a vein of the arm. It
More informationTo provide an evidenced-based approach to treatment of patients presenting with deep vein thrombosis.
DEEP VEIN THROMBOSIS: TREATMENT TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To provide an evidenced-based approach to treatment of patients presenting with deep vein thrombosis.
More informationA4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO)
A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO) Types of Catheter Related Thrombotic A catheter-related thrombus may be intraluminal (inside the catheter)
More informationACUTE DVT MANAGEMENT Richard J. DeMasi, MD April 26, 2014
ACUTE DVT MANAGEMENT Richard J. DeMasi, MD April 26, 2014 Thromboembolism epidemiology 5 million DVT s 900,000 PE s 290,000 fatalities Heit J. Blood. 2005;106:910. 10 VTE events Since this talk began DVT
More informationPATIENT GUIDE. Understand and care for your peripherally inserted central venous catheter (PICC). MEDICAL
PATIENT GUIDE Understand and care for your peripherally inserted central venous catheter (PICC). MEDICAL Introduction The following information is presented as a guideline for your reference. The best
More informationPreventing Blood Clots in Adult Patients. Information For Patients
Preventing Blood Clots in Adult Patients Information For Patients 1 This leaflet will give you information on how to reduce the risk of developing blood clots during and after your stay in hospital. If
More informationPARTICULAR ASPECTS OF ANTI-THROMBOTIC TREATMENT IN HIP ARTHROPLASTY
1 UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PARTICULAR ASPECTS OF ANTI-THROMBOTIC TREATMENT IN HIP ARTHROPLASTY ABSTRACT Ph.D student DR. TRUŞCĂ PAUL TIBERIU SCIENTIFIC COORDONATOR PROF. DR.VALENTIN
More information0.9% Sodium Chloride injection may be used in most cases.
Table 2. Alternatives to Heparin Sodium in Selected Situations 12-14 Situation Alternative Dose Maintain patency of peripheral venous catheters* 21-26 0.9% Sodium Chloride injection may be used in most
More informationDabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM
Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM This report was commissioned by the NIHR HTA Programme as project number 12/78
More informationInformation for you Treatment of venous thrombosis in pregnancy and after birth. What are the symptoms of a DVT during pregnancy?
Information for you Treatment of venous thrombosis in pregnancy and after birth Published in September 2011 What is venous thrombosis? Thrombosis is a blood clot in a blood vessel (a vein or an artery).
More informationWhat Does Pregnancy Have to Do With Blood Clots in a Woman s Legs?
Patient s Guide to Prevention of Blood Clots During Pregnancy: Use of Blood-Thinning A Patient s Guide to Prevention of Blood Clots During Pregnancy: Use of Blood-Thinning Drugs to Prevent Abnormal Blood
More informationLifecath Midline. A Nurses Guide to Lifecath Midline
Lifecath Midline A Nurses Guide to Lifecath Midline vygon@vygon.co.uk www.vygon.co.uk Lifecath Midline A Nurses Guide to Lifecath Midline This booklet provides guidance in the care and maintenance of Midline
More informationTunneled Central Venous Catheter (CVC) Placement
PATIENT EDUCATION patienteducation.osumc.edu Tunneled Central Venous Catheter (CVC) Placement A tunneled Central Venous Catheter (CVC) is a special type of intravenous (IV) line that is placed into a large
More informationJoseph A. Caprini, MD, MS, FACS, RVT
Joseph A. Caprini, MD, MS, FACS, RVT Louis W. Biegler Chair of Surgery NorthShore University HealthSystem, Evanston, IL Clinical Professor of Surgery University of Chicago Pritzker School of Medicine,
More informationVenous and Lymphatic Disorders
Venous and Lymphatic Disorders. ก. Venous and Lymphatic Disorders Varicose Veins Deep Vein Thrombosis (DVT) Lymphedema What Is Varicose Veins? Latin: Varicose = Varix = twisted Abnormal venous dilatation
More informationPICC & Midline Catheters Patient Information Guide
PICC & Midline Catheters Patient Information Guide medcompnet.com 1 table of contents Introduction 4 What is a PICC or Midline Catheter? 4 How is the PICC or Midline Catheter Inserted? 6 Catheter Care
More informationPeripherally Inserted Central Catheter (PICC) Benefits Long-term access - dwell time varies (can be > one year) Decreased length of stay in hospital a
Nursing Management of Venous Access Devices: Peripherally Inserted Central Catheter (PICC) Mimi Bartholomay, RN, MSN, AOCN Denise Dreher, RN, CRNI, VA-BC Theresa Evans, RN, MSN Susan Finn, RN, MSN, AOCNS
More informationUsing CDS (Clinical Decision Support) for Quality Initiatives at a Community Hospital
Using CDS (Clinical Decision Support) for Quality Initiatives at a Community Hospital Jonathan Sykes MD, CMIO Jacalyn Liebowitz RN, MBA,NEA-BCFACHE VP Care Continuum Allegiance Health - Jackson, MI DISCLAIMER:
More informationClive Kearon, Susan R. Kahn, Giancarlo Agnelli, Samuel Goldhaber, Gary E. Raskob and Anthony J. Comerota. DOI 10.1378/chest.
Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Clive Kearon, Susan R. Kahn, Giancarlo Agnelli,
More informationPeripherally Inserted Central Catheter
Peripherally Inserted Central Catheter (PICC) by Patricia Griffin Kellicker, BSN En Español (Spanish Version) Definition A peripherally inserted central catheter is a long, thin tube that is inserted through
More informationAntithrombotic Therapy for VTE Disease
CHEST Supplement ANTITHROMBOTIC THERAPY AND PREVENTION OF THROMBOSIS, 9TH ED: ACCP GUIDELINES Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American
More informationPICC/Midclavicular/Midline Catheter
47 PICC/Midclavicular/Midline Catheter Introduction- PICC/ MCV/ Midline You have a PICC/Midclavicular/Midline (peripherally inserted) catheter. This catheter should make receiving I.V. medicines or solutions
More informationVaxcel PICCs Valved and Non-Valved. A Patient s Guide
Vaxcel PICCs Valved and Non-Valved A Patient s Guide Information about your Vaxcel PICC is available by calling the Navilyst Medical Vascular Access Information Line 800.513.6876 Vaxcel Peripherally Inserted
More informationAntithrombotic Therapy for VTE Disease
CHEST Supplement ANTITHROMBOTIC THERAPY AND PREVENTION OF THROMBOSIS, 9TH ED: ACCP GUIDELINES Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American
More informationVenous Thrombosis and Pulmonary Embolism in Children and Young Adults
Venous Thrombosis and Pulmonary Embolism in MSRHTC P.O. Box 6507 Aurora, CO 80045-0507 (303) 724-0724 An Overview for Patients and Health Care Providers 2 15 GLOSSARY: venous thrombosis = a condition of
More informationGuy s, King s and St Thomas Cancer Centre The Cancer Outpatient Clinic Central venous catheter: Peripherally inserted central catheter
Guy s, King s and St Thomas Cancer Centre The Cancer Outpatient Clinic Central venous catheter: Peripherally inserted central catheter This information leaflet aims to help answer some of the questions
More informationX-Plain Subclavian Inserted Central Catheter (SICC Line) Reference Summary
X-Plain Subclavian Inserted Central Catheter (SICC Line) Reference Summary Introduction A Subclavian Inserted Central Catheter, or subclavian line, is a long thin hollow tube inserted in a vein under the
More informationDVT/PE Management with Rivaroxaban (Xarelto)
DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular
More informationThis means you! Appropriate training, supervision and procedural load is what determines outcome not clinician grade! Studies have shown that a clinic
PROMOTING VESSEL HEALTH & PRESERVATION: The RIGHT trained clinician will insert: The RIGHT vascular device in the: The RIGHT vessel for the: The RIGHT patient at the: The RIGHT time This means you! Appropriate
More informationNew Oral Anticoagulants. How safe are they outside the trials?
New Oral Anticoagulants How safe are they outside the trials? Objectives The need for anticoagulant therapy Indications for anticoagulation Traditional anticoagulant therapies Properties of new oral anticoagulants
More informationAnticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h
Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h See EMR adult VTE prophylaxis CI order set Enoxaparin See service specific dosing Assess
More informationINTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia
INTRODUCTION Thrombophilia (Hypercoagulability) is a condition in which a person forms blood clots more than normal. Blood clots may occur in the arms or legs (e.g., deep vein thrombosis DVT), the lungs
More informationPERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) Fong So Kwan APN, Haematology unit Medical Department, QMH
PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) Fong So Kwan APN, Haematology unit Medical Department, QMH 1 What is a PICC catheter? Primary vascular access device since their introduction in the mid-1970s,
More information6/19/2012. Update on Venous Thromboembolism Prophylaxis. Disclosure. Learning Objectives. No conflicts of interest to declare
Update on Venous Thromboembolism Prophylaxis Disclosure No conflicts of interest to declare Learning Objectives After completion of this presentation, participants should be able to: Define venous thromboembolism,
More informationUHS CLINICAL CARE COLLABORATION: Outpatient & Inpatient
Guidelines for Anticoagulation Initiation and Management Y2014 UHS CLINICAL CARE COLLABORATION: Outpatient & Inpatient Topic Page Number MEDICATION FLOW AND PATIENT FLOW... 2 AND 3 PARENTERAL ANTICOAGULANTS...
More informationSurgical Options for Venous Disease. Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart
Surgical Options for Venous Disease Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart Chronic Venous Disease Approximately 23% of adults in the US have varicose veins Estimated 22 million women
More informationNational Patient Safety Goals Effective January 1, 2015
National Patient Safety Goals Goal 1 Nursing are enter ccreditation Program Improve the accuracy of patient and resident identification. NPSG.01.01.01 Use at least two patient or resident identifiers when
More informationInpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.
Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight
More informationrivaroxaban 15 and 20mg film-coated tablets (Xarelto ) SMC No. (755/12) Bayer PLC
rivaroxaban 15 and 20mg film-coated tablets (Xarelto ) SMC No. (755/12) Bayer PLC 13 January 2012 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS
More informationTitle Use of rivaroxaban in suspected DVT in the Emergency Department Standard Operating Procedure. Author s job title. Pharmacist.
Document Control Title Use of rivaroxaban in suspected DVT in the Emergency Department Author Pharmacist Directorate Clinical Support Services Version Date Issued Status 0.1 Oct Draft 2015 1.0 Dec Final
More informationT.E.D. Anti-Embolism Stockings
T.E.D. Anti-Embolism Stockings You have been given this information because you are spending time in the hospital. This booklet contains important information about why you are wearing T.E.D. anti-embolism
More informationCLINICAL PRACTICE GUIDELINE: MOBILITY WITH A DEEP VEIN THROMBOSIS (DVT) Page 1 of 10
Page 1 of 10 1.0 FOCUS: Mobilization with a Deep Vein Thrombosis (DVT). The purpose of this clinical practice guideline (CPG) is to ensure that new knowledge is integrated across Fraser Health and to standardize
More informationNational Patient Safety Goals Effective January 1, 2015
National Patient Safety Goals Effective January 1, 2015 Goal 1 Improve the accuracy of resident identification. NPSG.01.01.01 Long Term are ccreditation Program Medicare/Medicaid ertification-based Option
More informationTrust Guideline for Thromboprophylaxis in Trauma and Orthopaedic Inpatients
A clinical guideline recommended for use In: By: For: Key words: Department of Orthopaedics, NNUHT Medical staff Trauma & Orthopaedic Inpatients Deep vein thrombosis, Thromboprophylaxis, Orthopaedic Surgery
More informationComponents of CVC Care Bundle. selection
Components of CVC Care Bundle Catheter site selection Site of insertion influences the subsequent risk for CR-BSI and phlebitis The influence of site is related in part to the risk for thrombophlebitis
More informationINTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia
INTRODUCTION Thrombophilia (Hypercoagulability) is a condition in which a person forms blood clots more than normal. Blood clots may occur in the arms or legs (e.g., deep vein thrombosis DVT), the lungs
More informationThrombosis and Hemostasis
Thrombosis and Hemostasis Wendy Lim, MD, MSc, FRCPC Associate Professor, Department of Medicine McMaster University, Hamilton, ON Overview To review the important developments in venous thromboembolism
More informationThe Art and Science of Infusion Nursing Bonnie J. Clemence, MSN, RN, CRNI Rhonda E. Maneval, DEd, MSN, RN
The Art and Science of Infusion Nursing Bonnie J. Clemence, MSN, RN, CRNI Rhonda E. Maneval, DEd, MSN, RN Risk Factors Associated With Catheter- Related Upper Extremity Deep Vein Thrombosis in Patients
More informationChronic Thromboembolic Disease. Chronic Thromboembolic Disease Definition. Diagnosis Prevention Treatment Surgical Nonsurgical
Chronic Thromboembolic Disease Diagnosis Prevention Treatment Surgical Nonsurgical Chronic Thromboembolic Disease Definition Pulmonary Hypertension due to chronic thromboembolism 6 months post acute PE:
More informationSCREENING COMPRESSION ULTRASOUND FOR LOWER EXTREMITY DVT
SCREENING COMPRESSION ULTRASOUND FOR LOWER EXTREMITY DVT R. Eugene Zierler, M.D. The D. E. Strandness, Jr. Vascular Laboratory University of Washington Medical Center Division of Vascular Surgery University
More informationV: Infusion Therapy. Alberta Licensed Practical Nurses Competency Profile 217
V: Infusion Therapy Alberta Licensed Practical Nurses Competency Profile 217 Competency: V-1 Knowledge of Intravenous Therapy V-1-1 V-1-2 V-1-3 V-1-4 V-1-5 Demonstrate knowledge and ability to apply critical
More informationOutpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2013
Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2013 General Principles: There is compelling data in the medical literature to support
More informationUnderstanding your Peripherally Inserted Central Catheter (PICC) Patient Information
Understanding your Peripherally Inserted Central Catheter (PICC) Patient Information The Purpose of this Information Sheet This information sheet has been written by patients, members of the public and
More informationPaul G. Lee. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume III, 1998-1999. A. Objective
A comparison of six months of anticoagulation with extended anticoagulation for a first episode of venous thromboembolism in patients with thrombophilia Paul G. Lee A. Objective a. To evaluate the risk
More informationPulmonary Embolic Disease: Caval Filtration and Other Stuff. Tony P. Smith, M.D. October 2, 2009
Pulmonary Embolic Disease: Caval Filtration and Other Stuff Tony P. Smith, M.D. October 2, 2009 Controversies in Treatment of Acute Pulmonary Embolic Disease Scope of the problem Transcatheter therapy
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: infusion_therapy_in_the_home 3/1998 2/2016 2/2017 2/2016 Description of Procedure or Service Home infusion
More informationTunneled Hemodialysis Catheters: Placement and complications
Tunneled Hemodialysis Catheters: Placement and complications Arif Asif, M.D. Director, Interventional Nephrology Associate Professor of Medicine University of Miami, FL Tunneled Hemodialysis Catheters:
More informationNational Guidance and New Protocols
National Guidance and New Protocols Dr Jane Strong Consultant Haematologist DVT clinical lead Acute VTE chair DAWN AC Twentieth User Group Meeting 8 th October 2012 Autumn dawn Restless geese take flight
More informationTo Bridge or Not to Bridge. Periop Anticoagulation Management. Don Weinshenker, MD Ambulatory Care Denver VAMC
To Bridge or Not to Bridge Periop Anticoagulation Management Don Weinshenker, MD Ambulatory Care Denver VAMC Financial Disclosure Information Nothing to report Periop AC Management Chronically anti-coagulated
More informationPulmonary Embolism Treatment Update
UC SF Pulmonary Embolism Treatment Update Jeffrey Tabas, MD Professor UCSF School of Medicine Emergency Department San Francisco General Hospital sf g h Disclosure No Financial Relationships to Disclose
More informationPROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults
PROTOCOL NUMBER: 7 PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults THIS PROTOCOL APPLIES TO: UW Health Clinics: all adult outpatients with an active order for warfarin TARGET
More informationEndovascular Repair of an Axillary Artery Aneurysm: A Novel Approach
Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach Bao- Thuy D. Hoang, MD 1, Jonathan- Hien Vu, MD 2, Jerry Matteo, MD 3 1 Department of Surgery, University of Florida College of Medicine,
More informationPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors
News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients
More informationManaging Your Non-Tunneled (Percutaneous) Catheter: PICC, SICC, and JCC. What is a PICC catheter?
Managing Your Non-Tunneled The staff of the Procedure, Vascular Access, Conscious Sedation Service has written this information to explain your new PICC (peripherally inserted central catheter), SICC (subclavian
More informationPICCs and Midline Catheters
Patient Education PICCs and Midline Catheters Patient s guide to PICC (peripherally inserted central catheter) and midline catheters What are PICCs and midline catheters used for? Any medicine given over
More informationPeripherally Inserted Central Catheter (PICC)
Peripherally Inserted Central Catheter (PICC) Disclaimer This is general information developed by The Ottawa Hospital. It is not intended to replace the advice of a qualified healthcare provider. Please
More informationCMS Limitations Guide - Radiology Services
CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
More informationADVICE ON TRAVEL-RELATED DEEP VEIN THROMBOSIS
ADVICE ON TRAVEL-RELATED DEEP VEIN THROMBOSIS Introduction 1. A possible link between deep vein thrombosis (DVT) and long haul air travel was first suggested by reports in medical journals in the 1950s.
More informationPeripherally Inserted Central Catheter (PICC)
Patient information leaflet Royal Surrey County Hospital NHS Foundation Trust Peripherally Inserted Central Catheter (PICC) Intravenous Therapy What is a PICC? A PICC is a very fine flexible tube measuring
More informationNational Guidance and New Protocols
National Guidance and New Protocols Dr Jane Strong Consultant Haematologist DVT clinical lead Acute VTE chair DAWN AC Twentieth User Group Meeting 8 th October 2012 DVT patient pathway Assessment Diagnosis
More informationPosition Statement: The Use of VTED Prophylaxis in Foot and Ankle Surgery
Position Statement: The Use of VTED Prophylaxis in Foot and Ankle Surgery Position Statement There is currently insufficient data for the (AOFAS) to recommend for or against routine VTED prophylaxis for
More informationHow To Take Xarelto
A patient's guide Your clinic's contact details are: Name: Contact number: Contents 2 Why have I been prescribed Xarelto? 2 What is Xarelto? 3 How do I take Xarelto? 3 What should I do if I miss a dose
More informationOmega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9
Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer
More informationRivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Final appraisal determination Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism This guidance was developed using
More informationTo define a diagnostic algorithm and treatment strategy for patients with acute pulmonary embolism.
PULMONARY EMBOLISM: DIAGNOSIS AND MANAGEMENT TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To define a diagnostic algorithm and treatment strategy for patients with acute pulmonary
More informationInnovations in Treating VTE, Using the EDOU
Innovations in Treating VTE, Using the EDOU Disclosures No financial conflicts or disclosures Kelly Sawyer, MD, MS kelly.sawyer@beaumont.edu Observation Symposium 2013 Objectives Overview of VTE Treatment
More informationCoronary Artery Disease leading cause of morbidity & mortality in industrialised nations.
INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.
More informationHemodialysis catheter infection
Hemodialysis catheter infection Scary facts In 2006, 82% of patients in the United States initiated dialysis via a catheter The overall likelihood of Tunneled cuffed catheters use was 35% greater in 2005
More informationImportance and Advantages of Intermittent External Pneumatic Compression Therapy in Venous Stasis Ulceration
Angiology Volume 56, Number 1, 2005 19 Importance and Advantages of Intermittent External Pneumatic Compression Therapy in Venous Stasis Ulceration Ufuk Alpagut, MD and Enver Dayioglu, MD, Istanbul, Turkey
More informationNon-surgical treatment of severe varicose veins
Non-surgical treatment of severe varicose veins Yasu Harasaki UCHSC Department of Surgery General Surgery Grand Rounds March 19, 2007 Definition Dilated, palpable, subcutaneous veins generally >3mm in
More informationRivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy
Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast Information for patients Pharmacy Your doctor has prescribed a tablet called rivaroxaban. This leaflet tells you about
More informationVenous thromboembolism: reducing the risk. Quick reference guide. Issue date: January 2010
Issue date: January 2010 Venous thromboembolism: reducing the risk Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital This guideline
More informationPreventing Blood Clots After Hip or Knee Replacement Surgery or Surgery for a Broken Hip. A Review of the Research for Adults
Preventing Blood Clots After Hip or Knee Replacement Surgery or Surgery for a Broken Hip A Review of the Research for Adults Is This Information Right for Me? Yes, if: You are considering or planning to
More informationAtrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE
Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE Clinical practice guidelines serve as an educational reference, and do not supersede the clinical judgment of the treating physician with
More informationGuidelines for diagnosis and management of acute pulmonary embolism
Guidelines for diagnosis and management of acute pulmonary embolism By Dr. Ahmed Zaghloul M.D. Anesthesia & Critical Care 2014 Predisposing factors for VTE Predisposing factor Strong predisposing factors
More informationGruppo di lavoro: Malattie Tromboemboliche
Gruppo di lavoro: Malattie Tromboemboliche 2381 Soluble Recombinant Thrombomodulin Ameliorates Hematological Malignancy-Induced Disseminated Intravascular Coagulation More Promptly Than Conventional Anticoagulant
More informationCLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014
CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 e 55 0495 2 Emergency Department (ED)- 1 Emergency Department Throughput Median time from
More informationTOTAL PARENTERAL NUTRITION (TPN) Revised January 2013
TOTAL PARENTERAL NUTRITION (TPN) Revised January 2013 OBJECTIVES Definition Indications for TPN administration Composition of TPN solutions Access routes for TPN administration Monitoring TPN administration
More informationEnoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants
Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants Traffic light classification- Amber 2 Information sheet for Primary Care Prescribers Relevant Licensed Indications
More informationThrombophilia. Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003
Thrombophilia Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003 Thrombophilia Hereditary and acquired risk factors for thrombosis Venous thromboembolism Arterial thromboembolism
More informationTony Melendez Version 2013 LINES, TUBES, PORTS, WHAT TO DO WITH THEM
Tony Melendez Version 2013 LINES, TUBES, PORTS, WHAT TO DO WITH THEM Discusion of the following PICC Line Hickman Cath Chest Tubes PICC s & Midlines Classic PICC Line A PICC line is essentially a narrow
More informationDisclosure. New Agents for Treatment of DVT. Prevalence of DVT VTE. Normal Hemostasis 7/17/2015. Mark Oliver, MD, RVT, RPVI,FSVU
New Agents for Treatment of DVT Disclosure PI Adopt and Amplify trials Mark Oliver, MD, RVT, RPVI,FSVU BMS and Pfizer Speaker VTE Venous Thromboembolism Recognized DVT s New : 170,000 Recurrent : 90,000
More informationOxford Anticoagulation & Thrombosis Service Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
Oxford University Hospitals NHS Trust Oxford Anticoagulation & Thrombosis Service Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Information for people with a blood clot (thrombus) What is this
More informationThe largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac
More information2.5mg SC daily. INR target 2-3 30 mg SC q 12 hr or 40mg daily. 10 mg PO q day (CrCl 30 ml/min). Avoid if < 30 ml/min. 2.
Anticoagulation dosing at UCDMC (SC=subcutaneously; CI=continuous infusion) Indication Agent Dose Comments Prophylaxis Any or No bleeding risk factors see adult heparin (VTE prophylaxis) IV infusion order
More informationPathway for the management of DVT in primary Care
Pathway for the management of DVT in primary Care Final Version: Approved by NHS DGS CCG: June 2015 This document aims to support practices in DGS CCG in the Management & Treatment of patients with suspected
More information6/3/2011. High Prevalence and Incidence. Low back pain is 5 th most common reason for all physician office visits in the U.S.
High Prevalence and Incidence Prevalence 85% of Americans will experience low back pain at some time in their life. Incidence 5% annual Timothy C. Shen, M.D. Physical Medicine and Rehabilitation Sub-specialty
More information